# AVEO PHARMACEUTICALS, INC.

AVEO PHARMACEUTICALS, INC. is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** AVEO PHARMACEUTICALS, INC.
- **Former names in filing history:** AVEO PHARMACEUTICALS INC (2005-04-27 to 2020-04-23)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boston, MA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001325879

## About

AVEO PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001325879, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-14, it reported annual revenue of USD 42,295,000; net income of USD -53,342,000; total assets of USD 105,341,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $42.3M (USD 42,295,000)
- **Net income:** -$53.3M (USD -53,342,000)
- **Total assets:** $105.3M (USD 105,341,000)
- **Cash and equivalents:** $70.5M (USD 70,542,000)
- **Operating cash flow:** -$57.3M (USD -57,257,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $6.0M (USD 6,019,000)
- **Net income:** -$35.6M (USD -35,584,000)
- **Total assets:** $66.9M (USD 66,912,000)
- **Cash and equivalents:** $61.8M (USD 61,761,000)
- **Operating cash flow:** -$38.0M (USD -37,983,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $28.8M (USD 28,795,000)
- **Net income:** $9.4M (USD 9,388,000)
- **Total assets:** $50.6M (USD 50,600,000)
- **Cash and equivalents:** $29.8M (USD 29,785,000)
- **Operating cash flow:** -$2.9M (USD -2,919,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $5.4M (USD 5,409,000)
- **Net income:** -$5.3M (USD -5,329,000)
- **Total assets:** $27.9M (USD 27,935,000)
- **Cash and equivalents:** $24.4M (USD 24,427,000)
- **Operating cash flow:** -$25.0M (USD -25,026,000)

## Recent SEC filings

- Form 8-K — filed 2023-01-19 — period 2023-01-19 — 8-K
- Form 8-K — filed 2023-01-18 — period 2023-01-17 — 8-K
- Form 8-K — filed 2023-01-05 — period 2023-01-05 — 8-K
- Form 8-K — filed 2022-12-02 — period 2022-12-01 — 8-K
- Form 8-K — filed 2022-11-07 — period 2022-11-07 — 8-K
- Form 10-Q — filed 2022-11-07 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-10-18 — period 2022-10-18 — 8-K
- Form 8-K — filed 2022-08-09 — period 2022-08-04 — 8-K
- Form 10-Q — filed 2022-08-04 — period 2022-06-30 — 10-Q
- Form 8-K — filed 2022-08-04 — period 2022-08-04 — 8-K
- Form 8-K — filed 2022-06-08 — period 2022-06-07 — 8-K
- Form 8-K — filed 2022-05-06 — period 2022-05-05 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/aveo-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology